secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2021-12-23T23:59:59+00:00
Accession:  0001628280-21-025555
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics board member Stella Xu resigns effective Jan 5, 2022
-------------------------------------------------------------------------

- Stella Xu notified the Board of her resignation on Dec 20, 2021, effective Jan 5, 2022.
- Resignation was not due to any disagreement with the company on operations, policies, or practices.
- No replacement has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000162828021025555/0001628280-21-025555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000162828021025555/tpst-20211220.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-025555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer